Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China / 中华内科杂志
Chinese Journal of Internal Medicine
; (12): 1206-1216, 2022.
Article
en Zh
| WPRIM
| ID: wpr-957679
Biblioteca responsable:
WPRO
ABSTRACT
Pulmonary arterial hypertension (PAH) is a clinicopathological syndrome caused by the increase of pulmonary artery, and it is the most serious complication of connective tissue disease (CTD). In recent years, a lot of progress has been made in the diagnosis, treatment and evaluation of PAH. Chinese Rheumatology Association formulated this recommendation on the basis of current experience and guidelines, in order to promote early screening, early diagnosis and early intervention of CTD-PAH, as well as patient follow-up and management, to improve the prognosis of CTD-PAH patients.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Internal Medicine
Año:
2022
Tipo del documento:
Article